Easing the Disease Burden of Patients With Atopic Dermatitis

To participate in this activity, please:

Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and topical JAK-STAT inhibitors.

This program is also available as a podcast.  You may download it here: https://anchor.fm/atopicdermatitis

Course Credit:

0.75 AMA PRA Category 1 CreditsTM


Opens: 2021-10-29
Closes: 2022-10-29

Target Audience:

This activity was developed for a national audience of dermatologists, pediatric dermatologists, allergists, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with atopic dermatitis.

This activity is supported by independent educational grants from AbbVie and Incyte.

    Presenting Faculty

  • Jonathan I. Silverberg, MD, PhD, MPH

    Director of Clinical Research
    Director of Patch Testing
    George Washington University School of Medicine and Health Sciences
    Washington, DC